Variant report
Variant | esv3354901 |
---|---|
Chromosome Location | chr8:6755742-6756890 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:6754502..6756661-chr8:6759647..6761646,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs571702060 | chr8:6755761-6755762 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs2738145 | chr8:6755762-6755763 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs75840679 | chr8:6755763-6755764 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs368883599 | chr8:6755814-6755815 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs2741056 | chr8:6755820-6755821 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs185000351 | chr8:6755831-6755832 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs117346199 | chr8:6755840-6755841 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs543141306 | chr8:6755896-6755897 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs563203752 | chr8:6755919-6755920 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs528497124 | chr8:6755921-6755922 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs560058906 | chr8:6755945-6755946 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs2978963 | chr8:6755957-6755958 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs146559631 | chr8:6755963-6755964 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs200784544 | chr8:6756016-6756017 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs10548608 | chr8:6756024-6756025 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs112588880 | chr8:6756025-6756026 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs76476399 | chr8:6756027-6756028 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs567512698 | chr8:6756032-6756033 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs13271126 | chr8:6756035-6756036 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs113017763 | chr8:6756040-6756041 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs13281734 | chr8:6756042-6756043 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs190235581 | chr8:6756046-6756047 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs13273258 | chr8:6756048-6756049 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs13274325 | chr8:6756055-6756056 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs13271147 | chr8:6756057-6756058 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs13281753 | chr8:6756064-6756065 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs13273280 | chr8:6756068-6756069 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs546584599 | chr8:6756080-6756081 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs2981406 | chr8:6756093-6756094 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs13281998 | chr8:6756106-6756107 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs150577946 | chr8:6756107-6756108 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs9693801 | chr8:6756112-6756113 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs372357803 | chr8:6756113-6756114 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs199917660 | chr8:6756114-6756115 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs111365781 | chr8:6756116-6756117 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs562824716 | chr8:6756123-6756124 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs373576674 | chr8:6756138-6756139 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs577895525 | chr8:6756144-6756145 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs565840996 | chr8:6756150-6756151 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs528349247 | chr8:6756153-6756154 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs543337332 | chr8:6756167-6756168 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs557232853 | chr8:6756169-6756170 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs376762897 | chr8:6756175-6756176 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs71517608 | chr8:6756183-6756184 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs28437170 | chr8:6756184-6756185 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs113653932 | chr8:6756185-6756186 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs376514125 | chr8:6756187-6756188 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs202062047 | chr8:6756190-6756191 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs28629829 | chr8:6756209-6756210 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs28645257 | chr8:6756210-6756211 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Autism | 22495311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Breast cancer | 21364760 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Gastric cancer | 18160780 | CNVD |
Breast cancer | 21990379 | CNVD |
Psoriasis | 20403174 | CNVD |
Psoriasis | 20663923 | CNVD |
Crohn''s disease | 16909382 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Crohn''s disease | 20877625 | CNVD |
Inflammatory disorder | 20877625 | CNVD |
Cardiac defect | 21933911 | CNVD |
Psoriasis | 18059266 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Psoriasis | 20877625 | CNVD |
Mental retardation | 17847001 | CNVD |
Prostate cancer | 17217626 | CNVD |
Schizophrenia | 21399695 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Psoriasis | 18848619 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Colorectal cancer | 17229543 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Bladder cancer | 21909424 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Cognitive impairment | 21505072 | CNVD |
Breast cancer | 17142309 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:6753000-6757400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr8:6753200-6760000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr8:6753200-6760000 | Weak transcription | Esophagus | oesophagus |
4 | chr8:6753400-6757800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
5 | chr8:6753400-6757800 | Weak transcription | HMEC | breast |
6 | chr8:6753400-6758000 | Weak transcription | NHEK | skin |
7 | chr8:6753600-6758000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
8 | chr8:6754000-6755800 | Enhancers | Dnd41 | blood |
9 | chr8:6754200-6757200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
10 | chr8:6755200-6756600 | Enhancers | Pancreas | Pancrea |
11 | chr8:6756400-6756600 | Enhancers | K562 | blood |
12 | chr8:6756600-6757400 | Weak transcription | Pancreas | Pancrea |
13 | chr8:6756600-6757400 | Active TSS | K562 | blood |